Use Able AI chat for product recommendations

TRPM6 Polyclonal antibody

TRPM6 Polyclonal Antibody for IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

IHC, IF/ICC, ELISA

CHAK2, Channel kinase 2, HMGX, HOMG, HOMG1, HSH, TRPM6

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for TRPM6 in ?

Tested Applications

Positive IF/ICC detected inHEK-293 cells

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)/ICCIF/ICC : 1:10-1:100
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

55455-1-AP targets TRPM6 in IHC, IF/ICC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name transient receptor potential cation channel, subfamily M, member 6
Calculated Molecular Weight 232 kDa
GenBank Accession NumberNM_017662
Gene Symbol TRPM6
Gene ID (NCBI) 140803
RRIDAB_2881341
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9BX84
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
IF protocol for TRPM6 antibody 55455-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The TRPM6 Polyclonal antibody (Cat# 55455-1-AP) has 1 total citation. It was cited in Cancer Immunology & Immunotherapy (IF 5.8) in a 2024 study by Maosheng Cheng et al., which used IHC to integrate bulk and single-cell sequencing data for constructing a dendritic cell-based prognostic model in esophageal squamous cell carcinoma (ESCC). The research field encompasses cancer immunology, tumor microenvironment analysis, and immune response prediction in gastrointestinal malignancies.

SpeciesApplicationTitle
humanIHC

Cancer Immunol Immunother

Integrating bulk and single-cell sequencing data to construct a Scissor+ dendritic cells prognostic model for predicting prognosis and immune responses in ESCC

Authors - Maosheng Cheng
Loading...
||
New chat

Able™

正在加载,请稍候...